top of page

Click on the Poster to View Larger

Search by
Poster Number

Poster 55

Kelley Tangredi
Apr 25, 2024
1 min read

Updated: Jun 27, 2024

Bimekizumab safety and tolerability in moderate to severe plaque psoriasis: Pooled analysis from up to 4 years of treatment in 5 phase 3/3b clinical trials

Authors: Gordon K.B., Thaçi D., Gooderham M., Okubo Y., Strober B., Peterson L., Deherder D., López Pinto J.M., Gisondi P.

<PREVIOUS POSTER | NEXT POSTER>

Poster 55

01, 02, 03, 04, 05, 06, 07, 08, 09, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64

bottom of page